contraindications for glp 1 agonists include GLP-1 Medications Infographic contraindications for glp 1 agonists

For the GLP-1 receptor agonists, the pooled event rates ranged from 1.6 to 2.7 per 1,000 patient-years

K., Patterson, R

The net effect across all three pathways: reduced appetite, improved insulin sensitivity, better glucose regulation, increased energy expenditure, and reduced liver fat

We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information contained herein

Available: [4] Cost of Inaction on Obesity, Obesity Canada

Patients on maintenance doses retained 70 to 85% of their peak weight loss at two years, compared to 40 to 60% retention for those who stopped completely but implemented lifestyle changes, and less than 30% for those who stopped without significant lifestyle modification